Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29986141 | 1.00 | GAA (0.36) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL3228085 | 1.00 | GAA (0.36) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL31692716 | 1.00 | GAA (0.36) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL12555541 | 0.93 | SOAT2 (0.38) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL15178888 | 0.73 | MAPT (0.31) | MAPT | |
| SCHEMBL12588536 | 0.73 | MAPT (0.31) | MAPT | |
| SCHEMBL9868912 | 0.71 | GAA (0.38) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5924360 | 0.71 | GAA (0.38) | GAALMNACYP3A4CYP2C9CYP2C19 | |
| SCHEMBL439631 | 0.71 | CACNA1G (0.32) | — | |
| SCHEMBL5924203 | 0.71 | PIK3CD (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109078221-B | Small-caliber artificial blood vessel co-modified by polyethylene glycol and polypeptide and preparation method thereof | 天津大学 | 2021-05-14 | — | — | CN | claimed |
| EP-3625292-B1 | METHOD OF PREPARING A PHYSICALLY CROSS-LINKED, LACTIDE-BASED POLYMER SYSTEM, POLYMER SYSTEM PREPARED BY THE METHOD, AND PROCESS OF MANUFACTURING AN OBJECT FROM THE POLYMER SYSTEM | HELMHOLTZ ZENTRUM HEREON GMBH (DE) | 2022-07-06 | — | — | EP | disclosed |
| CN-109078221-B | Small-caliber artificial blood vessel co-modified by polyethylene glycol and polypeptide and preparation method thereof | 天津大学 | 2021-05-14 | — | — | CN | disclosed |
| US-20200216606-A1 | Method of preparing a physically cross-linked, lactide-based polymer system, polymer system prepared by the method, and process of manufacturing an object from the polymer system. | HELMHOLTZ-ZENTRUM GEESTHACHT ZENTRUM FUER MATERIAL- UND KUESTENFORSCHUNG GMBH (DE) | 2020-07-09 | — | — | US | disclosed |
| EP-3625292-A1 | METHOD OF PREPARING A PHYSICALLY CROSS-LINKED, LACTIDE-BASED POLYMER SYSTEM, POLYMER SYSTEM PREPARED BY THE METHOD, AND PROCESS OF MANUFACTURING AN OBJECT FROM THE POLYMER SYSTEM | Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH (DE) | 2020-03-25 | — | — | EP | disclosed |
| WO-2019063609-A1 | METHOD OF PREPARING A PHYSICALLY CROSS-LINKED, LACTIDE-BASED POLYMER SYSTEM, POLYMER SYSTEM PREPARED BY THE METHOD, AND PROCESS OF MANUFACTURING AN OBJECT FROM THE POLYMER SYSTEM | Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH (DE) | 2019-04-04 | — | — | WO | disclosed |
| US-20100062036-A1 | Multiblock Copolymers with Shape-Memory Properties | GKSS-FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) | 2010-03-11 | — | — | US | disclosed |
| US-5466801-A | Process for the preparation of 3-, 6-substituted 2,5-morpholinediones | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-11-14 | — | — | US | disclosed |
| EP-0322154-B1 | Bioabsorbable polydepsipeptides, their preparation and use | PFIZER (US) | 1995-06-28 | — | — | EP | disclosed |
| WO-1994003441-A1 | PROCESS FOR THE PREPARATION OF 3-, 6-SUBSTITUTED 2,5-MORPHOLINEDIONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-02-17 | — | — | WO | disclosed |
| US-4994551-A | Sutures | PFIZER INC. (US) | 1991-02-19 | — | — | US | disclosed |
| US-4916209-A | SURGICAL SUTURES AND CLIPS | PFIZER INC. (US) | 1990-04-10 | — | — | US | disclosed |
| EP-0322154-A2 | Bioabsorbable polydepsipeptides, their preparation and use | PFIZER INC. (US) | 1989-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062036-A1 | Multiblock Copolymers with Shape-Memory Properties | PUF60, DDOST, PCBP1 | GAA 513/4885LMNA 2720/4885CYP3A4 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.